Literature DB >> 24562412

Choroidal thickness is affected by many factors which may change the effect of ranibizumab: author's response.

Tadayuki Nishide1, Natsuki Hayakawa, Etsuko Shibuya, Yoko Yagi, Nobuhisa Mizuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562412     DOI: 10.1007/s00417-014-2597-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  4 in total

1.  Subfoveal choroidal thickness: the Beijing Eye Study.

Authors:  Wen Bin Wei; Liang Xu; Jost B Jonas; Lei Shao; Kui Fang Du; Shuang Wang; Chang Xi Chen; Jie Xu; Ya Xing Wang; Jin Qiong Zhou; Qi Sheng You
Journal:  Ophthalmology       Date:  2012-09-23       Impact factor: 12.079

2.  Choroidal thickness in relation to hypercholesterolemia on enhanced depth imaging optical coherence tomography.

Authors:  Ian Y Wong; Raymond L Wong; Paul Zhao; Wico W Lai
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

3.  Exercise-induced acute changes in systolic blood pressure do not alter choroidal thickness as measured by a portable spectral-domain optical coherence tomography device.

Authors:  Ahmad A Alwassia; Mehreen Adhi; Jason Y Zhang; Caio V Regatieri; Adeeb Al-Quthami; Deeb Salem; James G Fujimoto; Jay S Duker
Journal:  Retina       Date:  2013-01       Impact factor: 4.256

4.  Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy.

Authors:  Tadayuki Nishide; Natsuki Hayakawa; Misako Nakanishi; Mai Ishii; Shinya Okazaki; Ikuko Kimura; Etsuko Shibuya; Nobuhisa Mizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-18       Impact factor: 3.117

  4 in total
  1 in total

1.  Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients.

Authors:  Keiko Azuma; Ryo Asaoka; Aya Matsuda; Jihee Lee; Kimiko Shimizu; Hiroko Inui; Hiroshi Murata; Asako Ogawa; Motoshi Yamamoto; Tatsuya Inoue; Ryo Obata
Journal:  Clin Ophthalmol       Date:  2018-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.